Automated description from the Alliance of Genome Resources (Release 3.2)
Predicted to have cyclin-dependent protein serine/threonine kinase regulator activity. Predicted to be involved in G2/M transition of mitotic cell cycle; positive regulation of cyclin-dependent protein serine/threonine kinase activity; and regulation of canonical Wnt signaling pathway. Predicted to localize to cytoplasmic cyclin-dependent protein kinase holoenzyme complex; nucleus; and plasma membrane. Is expressed in several structures, including genitourinary system; gut; liver; mammary gland; and spleen. Orthologous to human CCNY (cyclin Y).